SCHEMBL17799648

SCHEMBL17799648

Cc1oncc1C(=O)N[C@H]1CC[C@H]1c1ccc(Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.53
▸ TAS1R3 Q7RTX0 1/20 0.47
▸ TAS1R1 Q7RTX1 1/20 0.47
▸ TAS1R2 Q8TE23 1/20 0.47
▸ AKT1 P31749 12/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ GMNN O75496 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ PIM1 P11309 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ AGTR1 P30556 1/20 0.39
▸ CCKBR P32239 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17799718 0.81 LMNA (0.53) LMNATAS1R3TAS1R1TAS1R2NPC1
SCHEMBL16372326 0.81 LMNA (0.53) LMNATAS1R3TAS1R1TAS1R2NPC1
SCHEMBL17799709 0.78 TAS1R3 (0.40) TAS1R3TAS1R1TAS1R2AKT1SLC6A3
SCHEMBL17799699 0.78 NPC1 (0.51) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL16371986 0.78 NPC1 (0.51) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL16371875 0.76 P2RX7 (0.47) TAS1R3TAS1R1TAS1R2AKT1NPC1
SCHEMBL17799694 0.76 P2RX7 (0.47) TAS1R3TAS1R1TAS1R2AKT1NPC1
SCHEMBL17799703 0.76 AKT1 (0.39) TAS1R3TAS1R1TAS1R2AKT1
SCHEMBL17799705 0.75 NPC1 (0.47) NPC1RAB9ACYP1A2CYP2C19HCRTR1
SCHEMBL17799655 0.74 HSD17B10 (0.49) LMNAAKT1NPC1RAB9ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE50724-E1 4-membered ring carboxamides used as nematicides SYNGENTA CROP PROTECTION AG (CH) 2026-01-06 — — US disclosed
US-9867371-B2 4-membered ring carboxamides used as nematicides SYNGENTA PARTICIPATIONS AG (CH) 2018-01-16 — — US disclosed
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES TUBA3C, DDT, CYCS LMNA 3548/4885TAS1R3 3195/4885TAS1R1 3418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback